Item 7.01 Regulation FD Disclosure.
On June 4, 2021, Panbela Therapeutics, Inc. (the “Company”) issued a press
release regarding the presentation of clinical data at the American Society of
Clinical Oncology (ASCO) Annual Meeting taking place June 4-8, 2021. The text of
the press release is furnished as Exhibit 99.1 to this current report on Form
8-K and is incorporated herein by reference.
The information contained in this item 7.01 and Exhibit 99.1 is being furnished,
and shall not be deemed to be “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to liability under Section 18. Furthermore, the information contained in
this Item 7.01 and Exhibit 99.1 shall not be deemed to be incorporated by
reference into the Company’s filings under the Securities Act of 1933, as
amended, or the Exchange Act.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits Exhibit No. Description Method of Filing 99.1 Press release dated June 4, 2021 Furnished Electronically 2
© Edgar Online, source Glimpses